Dr. Reed Beall
Biography
Dr. Reed F. Beall is a population health researcher who works largely with medicine patent, regulatory, and utilization data to investigate the long-term impacts of national and international policy decisions which aim to balance incentives between equitable drug innovation and equitable drug access. He is an Assistant Professor in Healthcare Policy in the Department of Community Health Sciences within the Cumming School of Medicine and at the O’Brien Institute for Public Health at the University of Calgary. He also serves as affiliated faculty for the Program on Regulation, Therapeutics, and the Law (PORTAL) based within the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and Harvard Medical School. He has been invited to provide testimony on his research to the trilateral technical symposium of the World Health Organization, the World Intellectual Property Organization, and the World Trade Organization, as well as to the United Nations Secretary-General's High-Level Panel on Access to Medicines. Dr. Beall’s work has been published in Value in Health, Nature Biotechnology, Health Affairs, PLoS Medicine, and Social Science and Medicine, among others.
Education and Training
Postdoctoral: Program on Regulation, Therapeutics, and the Law (PORTAL) based within the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and Harvard Medical School; Doctoral: Population Health, University of Ottawa; Masters: International Policy Economy and Global Health Affairs, University of Denver; Undergraduate: Philosophy, University of Colorado at Boulder.
Research Interests and Expertise
Equitable pharmaceutical innovation and access to medicines; Healthcare disparities; Health inequities; Prescription drug and therapeutics policy; Intellectual property protection
Contact
